Literature DB >> 26952497

Chemically crosslinked nanogels of PEGylated poly ethyleneimine (l-histidine substituted) synthesized via metal ion coordinated self-assembly for delivery of methotrexate: Cytocompatibility, cellular delivery and antitumor activity in resistant cells.

Samira Sadat Abolmaali1, Ali Mohammad Tamaddon2, Samaneh Mohammadi3, Zohreh Amoozgar4, Rasoul Dinarvand5.   

Abstract

Self-assembled nanogels were engineered by forming Zn(2+)-coordinated micellar templates of PEGylated poly ethyleneimine (PEG-g-PEI), chemical crosslinking and subsequent removal of the metal ion. Creation of stable micellar templates is a crucial step for preparing the nanogels. To this aim, imidazole moieties were introduced to the polymer by Fmoc-l-histidine using carbodiimide chemistry. It was hypothesized the nanogels loaded with methotrexate (MTX), a chemotherapeutic agent, circumvent impaired carrier activity in HepG2 cells (MTX-resistant hepatocellular carcinoma). So, the nanogels were post-loaded with MTX and characterized by (1)H-NMR, FTIR, dynamic light scattering-zeta potential, atomic force microscopy, and drug release experiments. Cellular uptake and the antitumor activity of MTX-loaded nanogels were investigated by flow cytometry and MTT assay. Discrete, spherical and uniform nanogels, with sizes about 77-83 nm and a relatively high drug loading (54 ± 4% w/w), showed a low polydispersity and neutral surface charges. The MTX-loaded nanogels, unlike empty nanogels, lowered viability of HepG2 cells; the nanogels demonstrated cell-cycle arrest and apoptosis comparably higher than MTX as free drug that was shown to be through i) cellular uptake of the nanogels by clathrin-mediated transport and ii) endosomolytic activity of the nanogels in HepG2 cells. These findings indicate the potential antitumor application of this preparation, which has to be investigated in-vivo.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antitumor activity; Cellular delivery; Cytocompatibility; In-vitro; Methotrexate; PEGylated poly ethyleneimine; Self-assembled nanogel; l-Histidine substitution

Mesh:

Substances:

Year:  2016        PMID: 26952497     DOI: 10.1016/j.msec.2016.02.045

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  5 in total

Review 1.  Stimulus-responsive polymeric nanogels as smart drug delivery systems.

Authors:  Sakineh Hajebi; Navid Rabiee; Mojtaba Bagherzadeh; Sepideh Ahmadi; Mohammad Rabiee; Hossein Roghani-Mamaqani; Mohammadreza Tahriri; Lobat Tayebi; Michael R Hamblin
Journal:  Acta Biomater       Date:  2019-05-13       Impact factor: 8.947

2.  Core-Shell Imidazoline-Functionalized Mesoporous Silica Superparamagnetic Hybrid Nanoparticles as a Potential Theranostic Agent for Controlled Delivery of Platinum(II) Compound.

Authors:  Mehdi Abedi; Samira Sadat Abolmaali; Mozhgan Abedanzadeh; Fatemeh Farjadian; Soliman Mohammadi Samani; Ali Mohammad Tamaddon
Journal:  Int J Nanomedicine       Date:  2020-04-20

3.  Effect of PEGylation on assembly morphology and cellular uptake of poly ethyleneimine-cholesterol conjugates for delivery of sorafenib tosylate in hepatocellular carcinoma.

Authors:  Maryam Monajati; Shirin Tavakoli; Samira Sadat Abolmaali; Gholamhossein Yousefi; AliMohammad Tamaddon
Journal:  Bioimpacts       Date:  2018-04-18

4.  Co-condensation synthesis of well-defined mesoporous silica nanoparticles: effect of surface chemical modification on plasmid DNA condensation and transfection.

Authors:  Mahdokht Mahmoodi; Abbas Behzad-Behbahani; Sadigheh Sharifzadeh; Samira Sadat Abolmaali; AliMohammad Tamaddon
Journal:  IET Nanobiotechnol       Date:  2017-12       Impact factor: 1.847

5.  Redox-sensitive, PEG-shielded carboxymethyl PEI nanogels silencing MicroRNA-21, sensitizes resistant ovarian cancer cells to cisplatin.

Authors:  Sanaz Javanmardi; Ali Mohammad Tamaddon; Mahmoud Reza Aghamaali; Ladan Ghahramani; Samira Sadat Abolmaali
Journal:  Asian J Pharm Sci       Date:  2018-12-01       Impact factor: 6.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.